What are pharmacies selling for? UK market figures explained
Pharmacy brokers publish regular market commentary, and the headline numbers do not always agree. This page sets out what two of the largest brokers have reported for 2025, and explains why the figures can differ. We have taken these figures from published broker commentary and press coverage; before relying on any of them, check the broker's own report. Last reviewed: November 2026.
Reported figures side by side
| Measure | Reported by | Figure |
|---|---|---|
| Average goodwill per £1 of turnover | Hutchings Consultants | £0.76 in 2025 (£0.80 in 2024; £0.88 in 2023) |
| Average price achieved vs previous year | Christie & Co | Up 4.1% (after a 6.3% decline in 2024) |
| Share of asking price achieved | Christie & Co | Around 90% in first half of 2025 (94% in 2024) |
| First-time buyers | Christie & Co / Hutchings | 31% of Christie & Co sales in 2025 / 76% of Hutchings new registrations |
| Sale structure | Christie & Co | 52% asset sales, 48% share sales (2025) |
| Share of instructions from corporates and multiples | Hutchings Consultants | 71% in 2025 |
Why the numbers differ
- Different measures. Goodwill per £1 of turnover and average price achieved are not the same thing, and one can fall while the other rises if the mix of businesses sold changes.
- Different samples. Each broker reports on its own transactions, which may differ in size, region and type.
- Different definitions. "First-time buyers" as a share of sales and as a share of new registrations are different denominators.
That is why a single average is a poor guide to what one particular pharmacy is worth. See what affects a pharmacy's value.
What it means for buyers and sellers
Buyers: first-time buyers are a large group and some corporate disposals are coming to market, so prepare finance early. See the first-time buyer guide.
Sellers: asking prices and achieved prices can differ, so preparation and realistic expectations matter. See how to sell a pharmacy.
Sources: Christie & Co market commentary and Business Outlook 2026; Hutchings Consultants market commentary as reported in trade press. Figures are the brokers' own and unaudited by Pharmacy Brokers.